Last reviewed · How we verify
NCT05030051
A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Skinpen on Male and Female Subjects' Dorsal Hands as a Treatment of Hand Aging
NA trial testing SkinPen Precision System in Skin Aging in 18 participants. Completed in 30 November 2022.
30 June 2022
Quick facts
| Lead sponsor | Crown Laboratories, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 18 |
| Start date | 12 March 2021 |
| Primary completion | 30 June 2022 |
| Estimated completion | 30 November 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- SkinPen Precision System
Conditions studied
- Skin Aging — all drugs for Skin Aging →
Sponsor
Crown Laboratories, Inc. — full company profile →
Who can join
Adults 50 to 75, any sex, with Skin Aging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This proof of concept study is being conducted over the course of 60 days followed by a 3-month post-treatment visit to assess the efficacy and tolerability of the Sponsor's SkinPen device when used to treat men and women with signs of aging on the dorsum of the hands. Overall assessment of clinical outcome and safety will be based on the evaluation of pre-and post-treatment photos comparing baseline to final visit. The subject's assessment of satisfaction will also be evaluated at Visit 3 and Visit 4. Finally, both the clinician's and subject's assessments will be characterized using a clinician assessment scale at the 3-month post-treatment visit.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05030051
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Skin Aging
Currently open trials in the same condition.
- NCT07381218 — Focused Ultrasound Treatment for Facial Skin Laxity · NA · active not recruiting
- NCT06900660 — Evaluation of the Skin-Beautifying Effects of Collagen Drinks · NA · active not recruiting
- NCT06804772 — A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the · NA · active not recruiting
- NCT06816069 — Study on Safety and Efficacy of Monopolar Radio Frequency Device for Facial Skin Tightening · NA · active not recruiting
- NCT06727292 — Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo · NA · recruiting
Other Crown Laboratories, Inc. trials
Trials by the same sponsor.
- NCT05053022 — A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo · NA · completed
- NCT05071274 — A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Microneedling With SkinPen in Female and Male Subj · NA · completed
- NCT03173547 — A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05030051 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Crown Laboratories, Inc.
- Last refreshed: 18 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05030051.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing